Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132496) titled 'Plant-Derived Recombinant Human Serum Albumin After Successful Reperfusion in Large-Core Acute Ischemic Stroke: The ALIVE Trial' on Sept. 15.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The 2nd Affiliated Hospital of Chongqing Medical University
Condition:
Acute ischemic stroke with a large ischemic core due to anterior circulation large vessel occlusion confirmed by CTA/MRA/DSA (terminal internal carotid artery [ICA], middle cerebral artery [MCA] M1 or M2 segment).
Intervention:
Control group:Patients will receive endovascular treatment and standard medical therapy.
Recruitm...